IL309053A - Methods for treating atopic dermatitis and related disorders - Google Patents
Methods for treating atopic dermatitis and related disordersInfo
- Publication number
- IL309053A IL309053A IL309053A IL30905323A IL309053A IL 309053 A IL309053 A IL 309053A IL 309053 A IL309053 A IL 309053A IL 30905323 A IL30905323 A IL 30905323A IL 309053 A IL309053 A IL 309053A
- Authority
- IL
- Israel
- Prior art keywords
- methods
- atopic dermatitis
- related disorders
- treating atopic
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108379.5A GB202108379D0 (en) | 2021-06-11 | 2021-06-11 | Methods for treating a topic dermatitis and related disorders |
| PCT/EP2022/065851 WO2022258814A1 (en) | 2021-06-11 | 2022-06-10 | Methods for treating atopic dermatitis and related disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL309053A true IL309053A (en) | 2024-02-01 |
Family
ID=76954592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL309053A IL309053A (en) | 2021-06-11 | 2022-06-10 | Methods for treating atopic dermatitis and related disorders |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250059269A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4351641A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024522620A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022289697A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3221119A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB202108379D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309053A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202317184A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022258814A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20260234236A1 (en) * | 2023-02-13 | 2026-08-13 | Intervet Inc. | Canine antibodies to canine il-13 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| KR101363777B1 (ko) | 2005-09-30 | 2014-02-14 | 메디뮨 리미티드 | 인터루킨―13 항체 조성물 |
| WO2017139290A1 (en) * | 2016-02-10 | 2017-08-17 | Medimmune, Llc | Tralokinumab delivery device |
| JP2020509025A (ja) | 2017-03-01 | 2020-03-26 | メドイミューン・リミテッドMedImmune Limited | モノクローナル抗体製剤 |
-
2021
- 2021-06-11 GB GBGB2108379.5A patent/GB202108379D0/en not_active Ceased
-
2022
- 2022-06-10 TW TW111121662A patent/TW202317184A/zh unknown
- 2022-06-10 EP EP22733594.0A patent/EP4351641A1/en active Pending
- 2022-06-10 WO PCT/EP2022/065851 patent/WO2022258814A1/en not_active Ceased
- 2022-06-10 IL IL309053A patent/IL309053A/en unknown
- 2022-06-10 JP JP2023575802A patent/JP2024522620A/ja active Pending
- 2022-06-10 AU AU2022289697A patent/AU2022289697A1/en active Pending
- 2022-06-10 US US18/566,712 patent/US20250059269A1/en active Pending
- 2022-06-10 CA CA3221119A patent/CA3221119A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP4351641A1 (en) | 2024-04-17 |
| GB202108379D0 (en) | 2021-07-28 |
| JP2024522620A (ja) | 2024-06-21 |
| AU2022289697A1 (en) | 2023-12-21 |
| TW202317184A (zh) | 2023-05-01 |
| US20250059269A1 (en) | 2025-02-20 |
| WO2022258814A1 (en) | 2022-12-15 |
| CA3221119A1 (en) | 2022-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL290455A (en) | Methods of treating psychological and brain disorders | |
| IL288061A (en) | Compounds and methods for the treatment of covid-19 | |
| IL291687A (en) | Methods for treating myelofibrosis and related conditions | |
| IL280919A (en) | Methods of treating aging-related disorders | |
| PL3865102T3 (pl) | Urządzenie i sposób leczenia zaburzeń neurologicznych układu słuchowego | |
| IL264510A (en) | Methods and compositions for treatment of epileptic disorders | |
| PH12019500929A1 (en) | Anti il-33 antibodies and uses thereof | |
| IL294594A (en) | Methods of treating pemphigus | |
| IL262660A (en) | Compositions for and method of treating acid-base disorders | |
| IL262803B (en) | Methods of treating circadian rhythm sleep disorders | |
| IL285627A (en) | Systems and methods for the treatment of symptoms associated with migraines | |
| EP3471746A4 (en) | METHOD AND COMPOSITION FOR TREATING CRAMPING SEASONS | |
| IL313097A (en) | Methods of treating cns disorders | |
| IL274223A (en) | Methods for treating acid-base disorders | |
| DK3737423T3 (da) | Sammensætninger og fremgangsmåder til behandling af nethindelidelser | |
| EP4231000A4 (en) | PREDICTION METHOD AND PREDICTION DEVICE | |
| EP3784280A4 (en) | TREATMENT OF ATOPIC DERMATITIS | |
| EP3436427A4 (en) | METHOD AND COMPOSITION FOR TREATING NEURONIC HYPERREMARKABILITY | |
| IL313539A (en) | Methods for treating neurological disorders | |
| MA51647A (fr) | Compositions et méthodes pour le traitement de la dermatite atopique et la sélection du traitement | |
| EP4167037A4 (en) | PREDICTION SCORE CALCULATION DEVICE, PREDICTION SCORE CALCULATION METHOD, PREDICTION SCORE CALCULATION PROGRAM, AND LEARNING DEVICE | |
| EP3555116A4 (en) | THROMBIN INHIBITORS FOR THE TREATMENT OF CEREBRAL VASCULAR ACCIDENT AND RELATED BLEEDING DISORDERS | |
| IL311581A (en) | Compositions and methods for the treatment of pcdh19 related disorders | |
| EP3592423A4 (en) | METHOD FOR TREATMENT OF PELVIC PAIN, CHRONIC PROSTATITIS AND / OR SYMPTOMS OF AN OVERACTIVE BLADDER | |
| EP3447641A4 (en) | SOUND EFFECT PROCESSING AND UNIT |